Macquarie Group’s CARGO Therapeutics CRGX Stock Holding History

Macquarie Group’s Portfolio CRGX Stock Details CRGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-69	Closed	-$1.13K	–	1717
2024 Q2	$1.13K	Buy	+69	New	+$1.31K	﹤0.01%	1837

Other funds holding CRGX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Macquarie Group's CRGX Position: Q3 2024 in Review

Macquarie Group sold out of CARGO Therapeutics (CRGX) in Q3 2024, closing a stake of 69 shares — an estimated $1.13K sold.

Macquarie Group first reported a position in CRGX in Q2 2024 and held it in 1 quarter. The position peaked at $1.13K in Q2 2024. 79 funds tracked by Wall St. Rank hold CRGX as of Q3 2024.

Macquarie Group reported no remaining CARGO Therapeutics position as of Q3 2024 after selling out during the quarter.
Macquarie Group sold 69 CARGO Therapeutics shares in Q3 2024, an estimated $1.13K.
Macquarie Group first reported a position in CARGO Therapeutics in Q2 2024 and held it in 1 quarter.
Macquarie Group's CARGO Therapeutics position peaked at $1.13K in Q2 2024.
79 funds tracked by Wall St. Rank held CARGO Therapeutics as of Q3 2024.

Based on Macquarie Group's 13F filing for Q3 2024, filed 14 Nov 2024.